Related Experiment Video

Updated: Mar 30, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
11:48

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

17.6K

RSV infections: State of the art

Giovanni Piedimonte1,2,3

  • 1Chairman, Pediatric Institute, Cleveland Clinic, Cleveland, OH, USA.

Cleveland Clinic Journal of Medicine
|November 12, 2015
PubMed

Insights

Respiratory syncytial virus (RSV) causes common infant respiratory illness. Future treatments may focus on immune response modulation rather than direct antiviral agents.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Immunology

Background:

  • Respiratory syncytial virus (RSV) is a leading cause of lower respiratory illness in infants globally.
  • Effective cures for RSV remain a significant challenge despite extensive research.
  • Understanding RSV pathogenesis and risk factors is crucial for developing new interventions.

Purpose of the Study:

  • To review current understanding of RSV pathogenesis and risk factors.
  • To explore potential future therapeutic strategies for RSV infection.
  • To highlight the importance of host immune response modulation.

Main Methods:

  • Literature review of RSV pathogenesis and risk factors.
  • Analysis of current prophylaxis and management strategies.
  • Discussion of potential future treatment avenues.

Main Results:

  • Premature birth is the primary risk factor for severe RSV due to reduced maternal antibody transfer.
  • Infant susceptibility to RSV increases as maternal IgG antibody levels decrease in early infancy.
  • Current understanding suggests immune modulation may be more effective than direct antiviral therapies.

Conclusions:

  • Future RSV treatments are likely to target the host immune response.
  • Developing effective strategies requires a deep understanding of RSV's unique pathophysiologic mechanisms.
  • Continued research into host-pathogen interactions is essential for combating RSV.

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

11.6K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.4K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K